Drug:
Reaction: ANAEMIA
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25055292 |
ES |
36 | 2 |
Anaemia, Intermenstrual bleeding, |
||||
ADALIMUMAB, ADALIMUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MESALAMINE, |
||||
502 | 25055315 |
DE |
2 | |
Leukopenia, Neutropenia, Hypertension, Weight decreased, Herpes zoster, Pain, Anaemia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
503 | 25055500 |
RU |
||
Anaemia, Leukopenia, Abdominal adhesions, |
||||
OLAPARIB, OLAPARIB, BEVACIZUMAB, |
||||
504 | 25048356 |
JP |
||
Cerebral haemorrhage, Gastrointestinal haemorrhage, Haemobilia, Anal abscess, Haematochezia, Fatigue, Anaemia, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
505 | 25048378 |
NZ |
||
Anaemia, Deep vein thrombosis, Pulmonary embolism, Crohn^s disease, Vasculitis, |
||||
USTEKINUMAB, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, |
||||
506 | 25048442 |
IN |
64 | 1 |
Anaemia, Prostatic specific antigen increased, Malignant neoplasm progression, Fatigue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, DOCETAXEL, DOCETAXEL ANHYDROUS, ABIRATERONE ACETATE, ABIRATERONE, ENZALUTAMIDE, |
||||
507 | 25048549 |
CA |
80 | 1 |
Ulcer, Ventricular fibrillation, End stage renal disease, Chronic obstructive pulmonary disease, Anaemia, Aortic stenosis, Activated partial thromboplastin time prolonged, Drug ineffective, Abdominal distension, Product use in unapproved indication, Hyperlipidaemia, Gout, Incorrect route of product administration, |
||||
AMLODIPINE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, THEOPHYLLINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, SODIUM CITRATE, SODIUM CITRATE, SODIUM CITRATE, SODIUM CITRATE, SODIUM CITRATE, VITAMIN C, VITAMIN C, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, CALCIUM CARBONATE, ANTACID, PHYTONADIONE, PHYTONADIONE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, |
||||
508 | 25048597 |
RO |
2 | |
Thrombocytopenia, Anaemia, Foetal exposure during pregnancy, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
509 | 25048864 |
CZ |
21 | 2 |
Thrombocytopenia, Anaemia, Cytomegalovirus infection, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, RITUXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
510 | 25049241 |
JP |
70 | |
Myeloproliferative neoplasm, Acute myeloid leukaemia, Myelodysplastic syndrome, Neoplasm malignant, Nephroblastoma, Chronic myeloid leukaemia, Malaise, Anaemia, Blast cells present, |
||||
DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, LACOSAMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEMBOREXANT, |
||||
511 | 25049253 |
US |
2 | |
Anaemia, Red cell distribution width increased, Serum ferritin increased, Fatigue, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
512 | 25049341 |
RS |
||
Anaemia, Malignant neoplasm progression, |
||||
OLAPARIB, OLAPARIB, |
||||
513 | 25049484 |
JP |
73 | 1 |
Malignant neoplasm progression, Nausea, Anaemia, Neutrophil count decreased, Platelet count decreased, Eastern Cooperative Oncology Group performance status worsened, Rash, Malaise, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, |
||||
514 | 25049556 |
CA |
59 | 2 |
Anaemia, Arthralgia, Cardiac failure, Fatigue, Feeling cold, Gait disturbance, Hypotension, Inflammation, Injection site nodule, Injection site pain, Injection site swelling, Joint swelling, Movement disorder, Pain, Pain in extremity, Pelvic pain, Peripheral swelling, Pleurisy, Product use in unapproved indication, Pulmonary oedema, Sitting disability, Dyspnoea, Diarrhoea, Hypertension, Infection, Alopecia, Therapeutic response decreased, |
||||
LEFLUNOMIDE, SARILUMAB, SARILUMAB, AMLODIPINE, DEXLANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, LEVOTHYROXINE SODIUM, |
||||
515 | 25049693 |
CA |
||
Death, Anaemia, |
||||
NIRAPARIB, NIRAPARIB, NIRAPARIB, LEVOTHYROXINE SODIUM, CELECOXIB, CALCIUM, MAGNESIUM, |
||||
516 | 25050035 |
US |
58 | 1 |
Syncope, Anaemia, Oesophageal haemorrhage, |
||||
CAPECITABINE, TRASTUZUMAB, BEVACIZUMAB, OXALIPLATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LORAZEPAM, ENOXAPARIN SODIUM, POLYETHYLENE GLYCOL 3350, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, OXYCODONE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, UREA, CREAM, ERGOCALCIFEROL, ZINC ACETATE ANHYDROUS AND ZINC GLUCONATE, ZINC ACETATE ANHYDROUS, ZINC GLUCONATE, AND SAMBUCUS NIGRA FLOWERING TOP, ZINC ACETATE ANHYDROUS, ECHINACEA ANGUSTIFOLIA, AND ZINC GLUCONATE, ZOLPIDEM TARTRATE, |
||||
517 | 25050085 |
PL |
77 | 2 |
Anaemia, Neutropenia, |
||||
CISPLATIN, ETOPOSIDE, |
||||
518 | 25050180 |
US |
||
Anaemia, |
||||
SATRALIZUMAB, |
||||
519 | 25050256 |
BR |
51 | 2 |
Anaemia, Platelet count decreased, Decreased immune responsiveness, Skin discolouration, Ageusia, Oral discomfort, Gastritis, Oral disorder, Angular cheilitis, Nail cuticle fissure, Skin burning sensation, Depression, Discouragement, Constipation, Pruritus, Diarrhoea, Epistaxis, Acne, Skin exfoliation, Skin fissures, Abdominal pain, Dry skin, Dry mouth, Asthenia, Nausea, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
520 | 25050385 |
CA |
1 | |
Asthenia, Fatigue, Anaemia, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
521 | 25050967 |
MX |
77 | 1 |
Parkinson^s disease, Renal failure, Prostatic disorder, Visual impairment, Hypertension, Osteoporosis, Anaemia, Wrong technique in product usage process, |
||||
SACUBITRIL AND VALSARTAN, CARBAMAZEPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
522 | 25051254 |
|||
Myeloproliferative neoplasm, Malignant neoplasm progression, Anaemia, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, ERYTHROPOIETIN, ERYTHROPOIETIN, ERYTHROPOIETIN, |
||||
523 | 25051373 |
US |
55 | 1 |
Anaemia, |
||||
LENALIDOMIDE, |
||||
524 | 25051482 |
JP |
38 | 2 |
Cystitis haemorrhagic, Dysuria, Urinary retention, Haematuria, Urinary retention, Bladder pain, Cystitis noninfective, Renal impairment, Pyrexia, Jaundice, Anaemia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, OLANZAPINE, ZOLPIDEM TARTRATE, LANSOPRAZOLE, AMOXICILLIN AND CLAVULANATE POTASSIUM, DENOSUMAB, |
||||
525 | 25051711 |
GB |
2 | |
Ascites, Myelosuppression, Weight decreased, Tachycardia, Anaemia, Constipation, Tremor, Dyspnoea exertional, Muscle atrophy, Orthostatic hypotension, Decreased appetite, Abdominal pain upper, Vomiting, Dizziness, Blood potassium decreased, Blood magnesium decreased, Asthenia, Weight decreased, Muscular weakness, Alopecia, Oedema peripheral, |
||||
LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LANSOPRAZOLE, LANSOPRAZOLE, PANCRELIPASE, PANCRELIPASE, CAPECITABINE, TEMOZOLOMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, FLUCONAZOLE, FLUCONAZOLE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITUXIMAB, CALCIUM, CALCIUM, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, OCTREOTIDE ACETATE, OCTREOTIDE, ERGOCALCIFEROL, GANCICLOVIR SODIUM, GANCICLOVIR, PHYTONADIONE, |
||||
526 | 25052287 |
EG |
79 | 2 |
Pancytopenia, Anaemia, Leukopenia, Neutropenia, Thrombocytopenia, |
||||
PALBOCICLIB, FULVESTRANT, |
||||
527 | 25052381 |
US |
64 | 2 |
Anaemia, |
||||
LENALIDOMIDE, ACYCLOVIR, GLIPIZIDE, ENTECAVIR, SIMVASTATIN, |
||||
528 | 25052419 |
CA |
71 | 2 |
Hypoalbuminaemia, Pancreatitis, Feeding disorder, Dysphagia, Troponin increased, Eosinophilia, Liver injury, Status epilepticus, Shunt infection, Drug reaction with eosinophilia and systemic symptoms, Jaundice, Inflammation, Acute kidney injury, Anaemia, Cardiac murmur, Cardiac failure, Acute myocardial infarction, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RIFAMPIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ALLOPURINOL, CARBAMAZEPINE, VANCOMYCIN HYDROCHLORIDE, CEFUROXIME, |
||||
529 | 25052428 |
CN |
66 | |
Myelosuppression, Anaemia, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, PACLITAXEL, |
||||
530 | 25059552 |
19 | 2 | |
Myalgia, Fatigue, Anaemia, |
||||
UPADACITINIB, |
||||
531 | 25043489 |
US |
||
Malignant neoplasm progression, Anaemia, |
||||
OLAPARIB, OLAPARIB, |
||||
532 | 25043680 |
JP |
||
Neutropenia, Anaemia, Thrombocytopenia, Fatigue, Bacterial sepsis, COVID-19, Febrile neutropenia, Renal impairment, Sudden death, Septic shock, Gastric ulcer, Herpes zoster, Dementia, Pneumonia bacterial, |
||||
RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, POLATUZUMAB VEDOTIN, |
||||
533 | 25043926 |
JP |
8 | 2 |
Pleural effusion, Pneumothorax, Atypical mycobacterial infection, Infectious pleural effusion, Anaemia, |
||||
TOCILIZUMAB, SULFASALAZINE, |
||||
534 | 25043990 |
JP |
80 | 1 |
Respiratory failure, Pancytopenia, Renal impairment, Ear discomfort, Malaise, Blood pressure decreased, COVID-19, Anaemia, White blood cell count decreased, Platelet count decreased, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
535 | 25043995 |
CA |
73 | 2 |
Denture wearer, Respiratory tract congestion, Blood cholesterol increased, Urinary tract infection, Secretion discharge, Headache, Fall, Weight decreased, Abdominal pain, Condition aggravated, Joint swelling, Cough, Nocturia, Wheezing, Tooth abscess, Abdominal distension, Blood pressure diastolic decreased, Vaccination site pain, Dizziness, Blister infected, Pulmonary congestion, Scab, Nasopharyngitis, Tenderness, Tooth extraction, Chills, Respiratory rate increased, Mastication disorder, Chest discomfort, Nausea, Sputum discoloured, Toothache, Arthralgia, Fatigue, Lower respiratory tract infection, Pain, Contusion, Rhinorrhoea, Pulmonary function test decreased, Anaemia, Productive cough, Blister, Loss of personal independence in daily activities, Inappropriate schedule of product administration, Limb injury, Hot flush, Sleep disorder, Oxygen saturation increased, Sputum retention, Respiratory disorder, |
||||
PREDNISONE, SOLIFENACIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, CANDESARTAN, CANDESARTAN, CANDESARTAN, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, AMOXICILLIN AND CLAVULANATE POTASSIUM, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ALBUTEROL SULFATE, |
||||
536 | 25044133 |
US |
61 | 2 |
Neutropenia, Anaemia, |
||||
PACLITAXEL, PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, |
||||
537 | 25044230 |
VN |
2 | |
Haemorrhage, Heavy menstrual bleeding, Paroxysmal nocturnal haemoglobinuria, Aplastic anaemia, Anaemia, Graft versus host disease in gastrointestinal tract, Cytomegalovirus infection reactivation, Osteonecrosis, Infection, Arthralgia, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
538 | 25044256 |
US |
||
Internal haemorrhage, Anaemia, |
||||
TICAGRELOR, |
||||
539 | 25044267 |
CA |
||
Anaemia, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PREDNISONE, |
||||
540 | 25044367 |
PL |
35 | 2 |
Eye infection toxoplasmal, Cerebral toxoplasmosis, Retinitis, Prerenal failure, Bone disorder, Dehydration, Anaemia, Vomiting, |
||||
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, SULFADIAZINE, |
||||
541 | 25044557 |
CA |
39 | 2 |
Anaemia, Cervicogenic headache, Migraine without aura, Pineal gland cyst, Suicidal ideation, Tension headache, Drug intolerance, Somnolence, Dizziness, Headache, Nausea, Fatigue, Therapeutic product effect incomplete, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL TARTRATE, METOPROLOL, NALTREXONE, NAPROXEN, NAPROXEN SODIUM, RIZATRIPTAN BENZOATE, SUMATRIPTAN SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, UBROGEPANT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
542 | 25044740 |
CN |
50 | 2 |
Tumour rupture, Tumour haemorrhage, Anaemia, |
||||
543 | 25044812 |
IL |
66 | 2 |
Renal tubular necrosis, Drug ineffective, Thrombocytopenia, Anaemia, |
||||
DOXORUBICIN, ZOLEDRONIC ACID, HYDROXYCHLOROQUINE, DOXAZOSIN, DOXAZOSIN MESYLATE, HYDROCHLOROTHIAZIDE, FULVESTRANT, CAPECITABINE, EVEROLIMUS, EVEROLIMUS TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EXEMESTANE, EXEMESTANE, PALBOCICLIB, PACLITAXEL, VINORELBINE, |
||||
544 | 25044915 |
JP |
75 | 1 |
Neuropathy peripheral, Neutrophil count decreased, Malaise, Stomatitis, Anaemia, Platelet count decreased, Therapy partial responder, Blood albumin decreased, Taste disorder, |
||||
PEMBROLIZUMAB, OXALIPLATIN, |
||||
545 | 25044972 |
US |
2 | |
Immobile, Anaemia, Hypoalbuminaemia, C-reactive protein increased, Blood creatinine increased, Blood urea increased, Abdominal pain, Pruritus, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
546 | 25045469 |
US |
63 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Acute kidney injury, Human herpesvirus 6 infection reactivation, Anaemia, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, ACYCLOVIR, |
||||
547 | 25045551 |
58 | 1 | |
Anaemia, |
||||
ETANERCEPT, |
||||
548 | 25045605 |
US |
2 | |
Heavy menstrual bleeding, Anaemia, |
||||
APIXABAN, |
||||
549 | 25045719 |
IE |
58 | 1 |
Chronic lymphocytic leukaemia, Bone marrow failure, Chronic lymphocytic leukaemia recurrent, Reticulocytopenia, Hepatosplenomegaly, Anaemia, Pancytopenia, Gastrointestinal stromal tumour, Leukaemic infiltration, Lymphadenopathy, Drug ineffective, Spleen atrophy, Aplasia pure red cell, |
||||
BENDAMUSTINE HCL, IBRUTINIB, PIRTOBRUTINIB, ACALABRUTINIB, RITUXIMAB, IDELALISIB, OBINUTUZUMAB, VENETOCLAX, VENETOCLAX, |
||||
550 | 25045861 |
CA |
2 | |
Anaemia, |
||||
OCRELIZUMAB, BACLOFEN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
551 | 25046177 |
CN |
75 | 2 |
Gastric ulcer, Erosive duodenitis, Anaemia, Duodenal ulcer, Gastrointestinal disorder, Duodenal bulb deformity, Chronic gastritis, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
552 | 25046191 |
CA |
71 | 2 |
Rectal haemorrhage, Vaginal discharge, Erythema, Anaemia, Chronic sinusitis, Colitis, Pyrexia, Therapeutic product effect incomplete, Nausea, Colitis ulcerative, Oral candidiasis, Constipation, Paraesthesia oral, Pain, Infusion related reaction, Procedural pain, Malaise, Abdominal pain, Headache, Weight decreased, Off label use, Vaginal flatulence, Radiculopathy, Drug ineffective, Female genital tract fistula, Frequent bowel movements, Macular degeneration, Dyspepsia, Haematochezia, Proctitis, |
||||
OXYBUTYNIN CHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUTICASONE FUROATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, FENTANYL, FENTANYL, DIPHENHYDRAMINE HYDROCHLORIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CARBOXYMETHYLCELLULOSE SODIUM, ADALIMUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, MORPHINE SULFATE, PREDNISONE, NITROGLYCERIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ERTAPENEM, ERTAPENEM SODIUM, DESONIDE, FLUTICASONE PROPIONATE, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, NICOTINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VALSARTAN, GLYCERIN, GLYCERIN SUPPOSITORY, FLUTICASONE FUROATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, NADOLOL, TRIMETHOPRIM, NICOTINAMIDE, PREGABALIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, INFLIXIMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARBOXYMETHYLCELLULOSE SODIUM, VEDOLIZUMAB, VEDOLIZUMAB, HYDROMORPHONE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, MAGNESIUM OXIDE, CLARITHROMYCIN, GLYCERIN, GLYCERIN SUPPOSITORY, MAGNESIUM CARBONATE, HYDROCORTISONE, ALPRAZOLAM, FRUCTOSE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
553 | 25046244 |
BR |
2 | |
Anaemia, Infarction, Acute myocardial infarction, Pneumonitis, |
||||
ATEZOLIZUMAB, APALUTAMIDE, |
||||
554 | 25046506 |
US |
75 | 1 |
Anaemia, Illness, Product dose omission issue, Product availability issue, |
||||
PACRITINIB, |
||||
555 | 25046551 |
DE |
77 | 1 |
Pancytopenia, Leukopenia, Anaemia, Infection, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
556 | 25046611 |
PL |
68 | 1 |
Death, Syncope, Staphylococcal sepsis, Pancytopenia, Pyrexia, Febrile neutropenia, Pneumonia, Thrombocytopenia, Device related infection, Frequent bowel movements, Cardiovascular disorder, Dehydration, Haematuria, Abscess, Anaemia, Anaemia macrocytic, Blood albumin decreased, Protein total decreased, C-reactive protein increased, Hypotonia, Malaise, Polyneuropathy, Asthenia, Oral candidiasis, Drug ineffective, |
||||
BRENTUXIMAB VEDOTIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
557 | 25046710 |
TW |
||
Intestinal obstruction, Hypertension, Acute kidney injury, Renal impairment, Hypokalaemia, Sepsis, Thrombocytopenia, Anaemia, Neutropenia, Drug effective for unapproved indication, Left ventricular dysfunction, Diarrhoea, Electrolyte imbalance, Off label use, Hyponatraemia, Gastrointestinal disorder, Peripheral sensory neuropathy, Malaise, Constipation, Nausea, Vomiting, Fatigue, |
||||
TRASTUZUMAB, |
||||
558 | 25046749 |
US |
59 | 2 |
Neutropenia, Anaemia, Off label use, |
||||
PACLITAXEL, PACLITAXEL, NIVOLUMAB, NIVOLUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CAPECITABINE, CAPECITABINE, |
||||
559 | 25046790 |
AT |
1 | |
Anaemia, |
||||
ENZALUTAMIDE, TALAZOPARIB, |
||||
560 | 25046968 |
US |
49 | 1 |
Thrombocytopenia, Anaemia, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
561 | 25047000 |
US |
57 | 2 |
Thrombocytopenia, Cytokine release syndrome, Anaemia, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
562 | 25047149 |
RO |
51 | 1 |
Thrombocytopenia, Leukopenia, Neutropenia, Pneumonia bacterial, Acute respiratory failure, Secondary immunodeficiency, Thrombophlebitis, Anaemia, |
||||
DARATUMUMAB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
563 | 25047281 |
BR |
58 | 2 |
Carotid artery disease, Anaemia, Cardiac valve disease, Tendon disorder, Bursitis, Blood triglycerides decreased, Blood cholesterol decreased, |
||||
CLADRIBINE, |
||||
564 | 25047464 |
IT |
77 | 2 |
Pneumonia, Asthenia, Decreased appetite, Dyspnoea exertional, Anaemia, Fatigue, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, IPILIMUMAB, FOLIC ACID, AMOXICILLIN AND CLAVULANATE POTASSIUM, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
565 | 25048001 |
GB |
2 | |
Lower respiratory tract infection, Decreased immune responsiveness, Malaise, COVID-19, Anaemia, |
||||
SECUKINUMAB, |
||||
566 | 25050125 |
87 | 1 | |
Pain in extremity, Muscular weakness, Weight bearing difficulty, Haematoma muscle, Anaemia, Hypoaesthesia, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE, |
||||
567 | 25052213 |
88 | 2 | |
Anaemia, |
||||
BELZUTIFAN, |
||||
568 | 25038855 |
IT |
82 | 2 |
Abdominal pain upper, Haemorrhage, Anaemia, Loss of consciousness, |
||||
APIXABAN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
569 | 25038890 |
AU |
49 | 1 |
Pulmonary congestion, Hypoxia, Skin toxicity, Hypervolaemia, Hypoalbuminaemia, Oxygen saturation abnormal, Pleural effusion, Dyspnoea, Blood pressure increased, Anaemia, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, ALLOPURINOL, CANDESARTAN CILEXETIL, ENOXAPARIN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, |
||||
570 | 25039130 |
NZ |
||
Crohn^s disease, Gastrointestinal haemorrhage, Anaemia, Full blood count decreased, Crohn^s disease, Gastrointestinal haemorrhage, Anaemia, Full blood count decreased, |
||||
RIVAROXABAN, RIVAROXABAN, PREDNISONE, |
||||
571 | 25039178 |
JP |
||
Prothrombin time prolonged, International normalised ratio increased, Anaemia, Drug interaction, |
||||
WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, MACITENTAN, BOSENTAN, FUROSEMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MAGNESIUM OXIDE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, LEVOTHYROXINE, CARVEDILOL, |
||||
572 | 25039330 |
US |
2 | |
Anaemia, Drug resistance, |
||||
AMIKACIN, CLARITHROMYCIN, CEFOXITIN, CEFOXITIN SODIUM, LINEZOLID, |
||||
573 | 25039408 |
DE |
65 | 2 |
Death, Leukocytosis, Anaemia, White blood cell count decreased, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, |
||||
574 | 25039618 |
ES |
67 | 2 |
Pneumonia, Anaemia, Thrombocytopenia, Hypertension, |
||||
BEVACIZUMAB, CARBOPLATIN, DOXORUBICIN, |
||||
575 | 25039793 |
US |
||
Symptom recurrence, Anaemia, Venipuncture, Drug ineffective, |
||||
MOMELOTINIB, RUXOLITINIB, HYDROXYUREA, |
||||
576 | 25039929 |
GB |
2 | |
Malaise, Hallucination, auditory, Anaemia, Off label use, Treatment noncompliance, |
||||
OLANZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
577 | 25040013 |
CN |
49 | |
Myelosuppression, Platelet count decreased, Anaemia, |
||||
OLAPARIB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
578 | 25040014 |
FR |
78 | 1 |
Duodenal ulcer haemorrhage, Anaemia, Gastrointestinal polyp haemorrhage, Acute kidney injury, |
||||
DICLOFENAC, DICLOFENAC SODIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, RAMIPRIL, LACTULOSE, LANSOPRAZOLE, GABAPENTIN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
579 | 25040116 |
US |
58 | 2 |
Acute myocardial infarction, Acute respiratory failure, Autoimmune hepatitis, Chronic hepatic failure, Transaminases increased, Anaemia, Abdominal pain, Asthenia, Jaundice, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
580 | 25040167 |
JP |
59 | 1 |
Stomal varices, Stoma site haemorrhage, Anaemia, Loss of consciousness, Seizure, Splenomegaly, Venoocclusive liver disease, Portal hypertension, |
||||
CAPECITABINE, CAPECITABINE, CAPECITABINE, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, IRINOTECAN HYDROCHLORIDE, |
||||
581 | 25040291 |
IN |
32 | 1 |
Sickle cell anaemia with crisis, Rhinorrhoea, Skin hyperpigmentation, Skin ulcer, Affective disorder, Venous thrombosis, Wound, Irritability, Mydriasis, Generalised tonic-clonic seizure, Lacrimation increased, Pain, Tachycardia, Nausea, Vomiting, Muscle spasms, Hyperhidrosis, Tremor, Anaemia, Agitation, Behaviour disorder, Anxiety, Sleep disorder, Drug abuse, Drug dependence, Intentional product misuse, |
||||
ZOLPIDEM TARTRATE, |
||||
582 | 25040395 |
CA |
78 | 2 |
Bronchopulmonary aspergillosis allergic, Pain, Asthma, Oedema peripheral, Liver function test increased, Haemoptysis, Transaminases increased, Blood test abnormal, Pulmonary fibrosis, Pyrexia, Drug hypersensitivity, Upper respiratory tract infection, Pleural effusion, Pleuritic pain, Cough, Pulmonary mass, Blood calcium increased, Gastrooesophageal reflux disease, Musculoskeletal stiffness, Sputum discoloured, Bronchiectasis, Lung opacity, Hypoxia, Tremor, Wheezing, Aspiration, Obstructive airways disorder, Headache, Product dose omission issue, Fatigue, Constipation, Abdominal pain upper, Blood creatinine increased, Pneumonia, Asthenia, General physical health deterioration, Rales, Dyspnoea, Drug ineffective, Lower respiratory tract infection, Anaemia, Total lung capacity decreased, |
||||
PREGABALIN, ROSUVASTATIN, MOMETASONE FUROATE, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, RANITIDINE, RANITIDINE, RANITIDINE, OMALIZUMAB, MORPHINE SULFATE, MORPHINE SULFATE, MOMETASONE FUROATE, MOMETASONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, SENNA LEAF, NITROGLYCERIN, NITROGLYCERIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MONTELUKAST, MONTELUKAST, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, RISEDRONATE SODIUM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, CANDESARTAN, CANDESARTAN, BUDESONIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MORPHINE SULFATE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, CANDESARTAN, |
||||
583 | 25040399 |
FR |
40 | 2 |
Epistaxis, Melaena, Anaemia, Drug ineffective, |
||||
TRANEXAMIC ACID, HYDROXYUREA, URSODIOL, URSOSIOL, DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE, IRON, IRON, |
||||
584 | 25040404 |
TW |
||
Hypertension, Diarrhoea, Left ventricular dysfunction, Anaemia, Thrombocytopenia, Neutropenia, Sepsis, Acute kidney injury, Hyponatraemia, Hypokalaemia, Constipation, Nausea, Vomiting, Intestinal obstruction, Malaise, Fatigue, Peripheral sensory neuropathy, |
||||
TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
585 | 25040474 |
CA |
71 | 2 |
Drug ineffective, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Therapeutic product effect incomplete, Female genital tract fistula, Frequent bowel movements, Haematochezia, Infusion related reaction, Macular degeneration, Off label use, Oral candidiasis, Pain, Procedural pain, Proctitis, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Abdominal pain, Constipation, Dyspepsia, Erythema, Headache, Malaise, Nausea, Paraesthesia oral, Pyrexia, Weight decreased, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, FLUTICASONE FUROATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUTICASONE FUROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOXYMETHYLCELLULOSE SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, DESONIDE, HYDROMORPHONE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, VEDOLIZUMAB, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL CITRATE, FLUTICASONE PROPIONATE, FLUCONAZOLE, FRUCTOSE, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, NITROGLYCERIN, ADALIMUMAB, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROMORPHONE HYDROCHLORIDE, INFLIXIMAB, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, MUPIROCIN, MUPIROCIN CALCIUM, NADOLOL, NICOTINE, NICOTINAMIDE, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, PANTOPRAZOLE, MESALAMINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, PREGABALIN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, CARBOXYMETHYLCELLULOSE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIMETHOPRIM, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, OXYBUTYNIN CHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALSARTAN, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, FENTANYL, |
||||
586 | 25040551 |
US |
77 | 1 |
Anaemia, |
||||
LENALIDOMIDE, |
||||
587 | 25040748 |
PL |
67 | 1 |
Neutropenia, Anaemia, |
||||
FLUOROURACIL, FLUOROURACIL, |
||||
588 | 25040749 |
CA |
17 | 1 |
Enteritis, Gastrointestinal haemorrhage, Constipation, Pyrexia, Therapy non-responder, Anaemia, Haematemesis, Faeces discoloured, |
||||
METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FOLIC ACID, IRON, PANTOPRAZOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
589 | 25040753 |
SK |
33 | 2 |
Febrile neutropenia, Anaemia, Myasthenia gravis, Muscular weakness, Oxygen saturation decreased, Dysarthria, Dysphonia, Trendelenburg^s symptom, Dysphagia, Grip strength decreased, Dyspnoea, Eyelid disorder, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, BLEOMYCIN, BLEOMYCIN SULFATE, PREDNISONE, ACYCLOVIR, DAPSONE GEL, 5%, DAPSONE, DASPONE, FLUCONAZOLE, |
||||
590 | 25040780 |
79 | 1 | |
Anaemia, Hypoxia, Acidosis, Aphasia, |
||||
CARBOPLATIN, |
||||
591 | 25040786 |
79 | 1 | |
Anaemia, Hypoxia, Acidosis, Aphasia, |
||||
CARBOPLATIN, |
||||
592 | 25040810 |
AU |
||
Anaemia, Cardio-respiratory arrest, Diarrhoea, Dyspnoea, Fatigue, Insomnia, Nausea, Neuropathy peripheral, Neutropenia, Oedema peripheral, Plasma cell myeloma refractory, Pneumonia, Therapy partial responder, Thrombocytopenia, Tumour lysis syndrome, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, THALIDOMIDE, |
||||
593 | 25040827 |
PL |
71 | 1 |
Anaemia, Hypokalaemia, |
||||
594 | 25041024 |
VN |
2 | |
Graft versus host disease in gastrointestinal tract, Haemorrhage, Osteonecrosis, Heavy menstrual bleeding, Paroxysmal nocturnal haemoglobinuria, Aplastic anaemia, Cytomegalovirus infection reactivation, Anaemia, Infection, Arthralgia, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
595 | 25041568 |
CA |
59 | 2 |
Hypertension, Movement disorder, Infection, Product use in unapproved indication, Arthralgia, Dyspnoea, Cardiac failure, Injection site nodule, Inflammation, Hypotension, Pulmonary oedema, Sitting disability, Fatigue, Pain in extremity, Peripheral swelling, Pain, Joint swelling, Gait disturbance, Pelvic pain, Pleurisy, Injection site swelling, Diarrhoea, Therapeutic response decreased, Injection site pain, Alopecia, Anaemia, Feeling cold, |
||||
LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, DEXLANSOPRAZOLE, AMLODIPINE, SARILUMAB, SARILUMAB, ERGOCALCIFEROL, PREDNISONE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, LEVOTHYROXINE SODIUM, |
||||
596 | 25041695 |
FR |
14 | 2 |
Hypothyroidism, Fatigue, Diarrhoea, Anaemia, Thrombocytopenia, Off label use, Drug ineffective, Hypertension, |
||||
ETOPOSIDE, CARBOPLATIN, ETOPOSIDE, AXITINIB, THIOTEPA, |
||||
597 | 25041897 |
CA |
71 | 2 |
Abdominal pain, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Constipation, Drug ineffective, Dyspepsia, Erythema, Frequent bowel movements, Female genital tract fistula, Haematochezia, Headache, Infusion related reaction, Macular degeneration, Malaise, Nausea, Off label use, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Proctitis, Pyrexia, Radiculopathy, Rectal haemorrhage, Therapeutic product effect incomplete, Vaginal discharge, Vaginal flatulence, Weight decreased, |
||||
HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MORPHINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, FLUTICASONE FUROATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUTICASONE FUROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOXYMETHYLCELLULOSE SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLARITHROMYCIN, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, VEDOLIZUMAB, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL, FLUTICASONE PROPIONATE, FLUCONAZOLE, FRUCTOSE, GLYCERIN, GLYCERIN SUPPOSITORY, ADALIMUMAB, HYDROCHLOROTHIAZIDE, INFLIXIMAB, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, NADOLOL, NICOTINE, NICOTINAMIDE, PANTOPRAZOLE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TRIMETHOPRIM, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, OXYBUTYNIN CHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALSARTAN, |
||||
598 | 25041947 |
JP |
1 | |
Arthralgia, Anaemia, |
||||
RADIUM RA 223 DICHLORIDE, |
||||
599 | 25041999 |
JP |
77 | 1 |
Anaemia, |
||||
NECITUMUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
600 | 25042043 |
RU |
54 | 2 |
Asthenia, Ascites, Pulmonary embolism, Depressed level of consciousness, Pain, Cardiac arrest, Anaemia, Thrombocytopenia, Hypoproteinaemia, |
||||
PEMBROLIZUMAB, BISOPROLOL FUMARATE, APIXABAN, MORPHINE, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, CYANOCOBALAMIN, FOLIC ACID, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28